Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A mechanistic survey of Alzheimer's disease
Yijing Tang, Dong Zhang, Xiong Gong, et al.
Biophysical Chemistry (2021) Vol. 281, pp. 106735-106735
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 80
Mechanistic insights into the potential role of dietary polyphenols and their nanoformulation in the management of Alzheimer’s disease
Hind Muteb Albadrani, Payal Chauhan, Sumel Ashique, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116376-116376
Open Access | Times Cited: 14
Mechanisms of Ferroptosis and Emerging Links to the Pathology of Neurodegenerative Diseases
Yiyan Sun, Xiaohuan Xia, Diksha Basnet, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 61
Dietary Polyphenols as Therapeutic Intervention for Alzheimer’s Disease: A Mechanistic Insight
Syed Nasir Abbas Bukhari
Antioxidants (2022) Vol. 11, Iss. 3, pp. 554-554
Open Access | Times Cited: 43
The potential role of human islet amyloid polypeptide in type 2 diabetes mellitus and Alzheimer’s diseases
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 27
First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT6 Agents with a Beneficial Neuroprotective Profile against Alzheimer’s Disease
Patryk Pyka, Wawrzyniec Haberek, Małgorzata Więcek, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 1580-1610
Open Access | Times Cited: 11
Revolutionizing Alzheimer's treatment: Harnessing human serum albumin for targeted drug delivery and therapy advancements
D. Shastri, Vinit Raj, Sang‐Kil Lee
Ageing Research Reviews (2024) Vol. 99, pp. 102379-102379
Closed Access | Times Cited: 9
Exploring pathological link between antimicrobial and amyloid peptides
Yijing Tang, Yanxian Zhang, Dong Zhang, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 17, pp. 8713-8763
Open Access | Times Cited: 6
Long Non-Coding RNAs: Crucial Regulators in Alzheimer’s Disease Pathogenesis and Prospects for Precision Medicine
Chenbo Yang, Yiwei Li, Chao Chen, et al.
Molecular Neurobiology (2025)
Closed Access
Current amyloid inhibitors: therapeutic applications and nanomaterial-based innovations
Paula López-García, María M. Tejero-Ojeda, Marisela Morales, et al.
Progress in Neurobiology (2025), pp. 102734-102734
Closed Access
Urine biomarkers for Alzheimer's disease: A new opportunity for wastewater-based epidemiology?
Arnoldo Armenta-Castro, Mónica T. Núñez-Soto, Kassandra O. Rodríguez-Aguillón, et al.
Environment International (2024) Vol. 184, pp. 108462-108462
Open Access | Times Cited: 4
Decoding the role of the CCL2/CCR2 axis in Alzheimer’s disease and innovating therapeutic approaches: Keeping All options open
Reyhaneh Arfaei, Narges Mikaeili, Fatemeh Daj, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112328-112328
Closed Access | Times Cited: 4
Theranostic applications of peptide-based nanoformulations for growth factor defective cancers
Arnab Ghosh, Priyanka Maske, Vinay Patel, et al.
International Journal of Biological Macromolecules (2024) Vol. 260, pp. 129151-129151
Closed Access | Times Cited: 3
Synthesis, computational and experimental pharmacological studies for (thio)ether-triazine 5-HT6R ligands with noticeable action on AChE/BChE and chalcogen-dependent intrinsic activity in search for new class of drugs against Alzheimer's disease
Kinga Czarnota-Łydka, Sylwia Sudoł-Tałaj, Katarzyna Kucwaj‐Brysz, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115695-115695
Open Access | Times Cited: 9
Repurposing Antimicrobial Protegrin-1 as a Dual-Function Amyloid Inhibitor via Cross-seeding
Yijing Tang, Dong Zhang, Jie Zheng
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 17, pp. 3143-3155
Closed Access | Times Cited: 9
Characterization of Orange Peel Extract and Its Potential Protective Effect against Aluminum Chloride-Induced Alzheimer’s Disease
Nourhan M. Abd El-Aziz, Mohamed G. Shehata, Tawfiq Alsulami, et al.
Pharmaceuticals (2022) Vol. 16, Iss. 1, pp. 12-12
Open Access | Times Cited: 15
A Comparative Study between Lycorine and Galantamine Abilities to Interact with AMYLOID β and Reduce In Vitro Neurotoxicity
Arian Kola, Stefania Lamponi, Francesco Currò, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2500-2500
Open Access | Times Cited: 8
Recent Advances in Our Molecular and Mechanistic Understanding of Misfolded Cellular Proteins in Alzheimer’s Disease (AD) and Prion Disease (PrD)
Walter J. Lukiw
Biomolecules (2022) Vol. 12, Iss. 2, pp. 166-166
Open Access | Times Cited: 13
Cross-seeding enables repurposing of aurein antimicrobial peptides as a promoter of human islet amyloid polypeptide (hIAPP)
Yijing Tang, Dong Zhang, Xiong Gong, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 33, pp. 7920-7932
Closed Access | Times Cited: 7
Discovery of novel 5-(2-hydroxyphenyl)-2-phthalide-3(3H)-pyrazolones as balanced multifunctional agents against Alzheimer's disease
Shiqin Cong, Yichun Shi, Guangjun Yu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 250, pp. 115216-115216
Closed Access | Times Cited: 6
Repurposing of intestinal defensins as multi-target, dual-function amyloid inhibitors via cross-seeding
Yijing Tang, Dong Zhang, Xiong Gong, et al.
Chemical Science (2022) Vol. 13, Iss. 24, pp. 7143-7156
Open Access | Times Cited: 10
Proposal of novel ApoE4 inhibitors from the natural spice Cinnamon for the treatment of Alzheimer's disease: Ab initio molecular simulations
Divya Shaji, Abhinav Das, Ryo Suzuki, et al.
Biophysical Chemistry (2023) Vol. 296, pp. 106990-106990
Closed Access | Times Cited: 5
Advances in the Study of the Pathology and Treatment of Alzheimer’s Disease and Its Association with Periodontitis
Dan Tang, Chang Sun, Jumei Yang, et al.
Life (2023) Vol. 13, Iss. 11, pp. 2203-2203
Open Access | Times Cited: 5
Discovery of novel harmine derivatives as GSK‐3β/DYRK1A dual inhibitors for Alzheimer's disease treatment
Jingsong Qiu, Xiangling Feng, Huanhua Chen, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 2
Closed Access | Times Cited: 5
PACT - Prediction of amyloid cross-interaction by threading
Jakub W. Wojciechowski, W. Szczurek, Natalia Szulc, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top